LYEL Lyell Immunopharma, Inc.
Fundamentals / CIK 0001806952 / USDLyell Immunopharma, Inc. reported $15K in revenue and a net loss of $255.2M for the trailing twelve months ended September 30, 2026 (down 80.0% year over year), with a -1783580.0% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LYEL in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$15K -80.0% YoY
-
Operating Income TTM-$267.5M -1783580.0% margin
-
Net Income TTM-$255.2M -1701066.7% net margin
-
Diluted EPS TTM-$10.44 Split-adjusted
-
Free Cash Flow TTM-$140.0M -933100.0% FCF margin
-
Cash & ST Investments Sep 30, 2026$177.1M Total debt: $44.28M
Annual revenue and net income
7 fiscal years (2019 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $36K | $61K | $130K | $84.68M | $10.65M | $7.76M | $657K |
| Research & Development | $158.7M | $171.6M | $182.9M | $159.2M | $138.7M | $182.2M | $63.59M |
| Total Operating Expenses | $269.4M | $358.8M | $247.1M | $271.7M | $225.4M | $219.7M | $102.7M |
| Operating Income | -$269.4M | -$358.8M | -$247.0M | -$187.1M | -$214.8M | -$211.9M | -$102.1M |
| EBITDA | -$257.9M | -$339.1M | -$226.8M | -$169.0M | -$201.2M | -$207.6M | -$100.8M |
| Income Tax Expense | $0 | -- | -- | -- | -- | -- | -- |
| Net Income | -$274.4M | -$343.0M | -$234.6M | -$183.1M | -$250.2M | -$204.5M | -$129.4M |
| Basic EPS | -$16.06 | -$26.23 | -$18.70 | -$14.80 | -$36.80 | -$313.80 | -$480.80 |
| Diluted EPS | -$16.06 | -$26.23 | -$18.70 | -$14.80 | -$36.80 | -$313.80 | -$480.80 |
| Basic Shares Outstanding | 17.1M | 13.1M | 12.5M | 12.4M | 6.8M | 662.9K | 271 |
| Diluted Shares Outstanding | 17.1M | 13.1M | 12.5M | 12.4M | 6.8M | 662.9K | 271 |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0K | $4.0K | $2.0K | $6.0K | $15K | $8.0K | $7.0K | $11K |
| Research & Development | $40.90M | $39.52M | $36.60M | -- | $28.17M | $34.86M | $43.45M | -- |
| Total Operating Expenses | $48.30M | $47.34M | $44.26M | $127.7M | $37.27M | $47.15M | $57.37M | $201.2M |
| Operating Income | -$48.30M | -$47.34M | -$44.26M | -$127.6M | -$37.25M | -$47.14M | -$57.37M | -$201.1M |
| EBITDA | -$46.24M | -$45.12M | -$41.93M | -$125.2M | -$34.69M | -$44.01M | -$53.93M | -$196.1M |
| Net Income | -$45.53M | -$44.76M | -$24.15M | -$140.7M | -$38.85M | -$42.68M | -$52.20M | -$191.9M |
| Basic EPS | -$1.86 | -$1.92 | -$1.10 | -- | -$2.13 | -$2.89 | -$3.54 | -- |
| Diluted EPS | -$1.86 | -$1.92 | -$1.10 | -- | -$2.13 | -$2.89 | -$3.54 | -- |
| Basic Shares Outstanding | 24.4M | 23.4M | 21.9M | -- | 18.3M | 14.8M | 14.8M | -- |
| Diluted Shares Outstanding | 24.4M | 23.4M | 21.9M | -- | 18.3M | 14.8M | 14.8M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $60.18M | $105.6M | $145.6M | $123.6M | $293.8M | $140.4M |
| Short-Term Investments | $187.0M | $264.9M | $400.6M | $516.6M | $321.0M | $472.2M |
| Cash & Short-Term Investments | $247.2M | $370.5M | $546.2M | $640.2M | $614.8M | $612.6M |
| Total Current Assets | $260.9M | $379.6M | $554.7M | $651.3M | $626.3M | $617.5M |
| Property, Plant & Equipment, Net | $34.77M | $48.20M | $102.7M | $123.0M | $120.1M | $77.05M |
| Long-Term Investments | $0 | $13.01M | $16.51M | $70.12M | $283.5M | $80.00M |
| Other Non-Current Assets | $4.89M | $4.62M | $4.24M | $4.68M | $3.48M | $2.77M |
| Total Non-Current Assets | $79.11M | $111.3M | $195.3M | $286.3M | $501.1M | $290.7M |
| Total Assets | $340.1M | $490.9M | $750.0M | $937.6M | $1.13B | $908.3M |
| Accounts Payable | $2.89M | $5.37M | $4.82M | $3.92M | $3.21M | $9.40M |
| Deferred Revenue (Current) | -- | -- | -- | $0 | $4.99M | $6.09M |
| Total Current Liabilities | $49.41M | $53.79M | $34.52M | $37.03M | $46.74M | $49.28M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $79.67M | $89.07M |
| Other Non-Current Liabilities | $517K | $3.25M | $3.66M | $4.11M | $4.57M | $532K |
| Total Non-Current Liabilities | $42.44M | $54.25M | $60.56M | $67.28M | $150.9M | $140.6M |
| Total Liabilities | $91.85M | $108.0M | $95.08M | $104.3M | $197.6M | $189.8M |
| Total Debt (incl. Leases) | $50.99M | $58.97M | $63.17M | $67.70M | $67.82M | $54.57M |
| Common Stock | $2.0K | $1.0K | $25K | $25K | $24K | $2.0K |
| Retained Earnings | -$1.62B | -$1.35B | -$1.00B | -$767.5M | -$584.4M | -$334.1M |
| Accumulated Other Comp. Income | $242K | $291K | -$94K | -$7.60M | -$1.62M | $256K |
| Total Stockholders' Equity | $248.2M | $382.8M | $655.0M | $833.3M | $929.8M | -$292.5M |
| Total Equity | $248.2M | $382.8M | $655.0M | $833.3M | $929.8M | -$292.5M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $92.05M | $72.98M | $90.77M | $60.18M | $123.6M | $98.80M | $120.3M | $105.6M |
| Short-Term Investments | $85.05M | $131.1M | $163.3M | $187.0M | $196.0M | $178.0M | $180.8M | $264.9M |
| Cash & Short-Term Investments | $177.1M | $204.1M | $254.0M | $247.2M | $319.6M | $276.8M | $301.2M | $370.5M |
| Total Current Assets | $186.2M | $213.5M | $267.3M | $260.9M | $328.2M | $282.2M | $309.2M | $379.6M |
| Property, Plant & Equipment, Net | $28.53M | $30.51M | $32.72M | $34.77M | $36.72M | $39.12M | $44.20M | $48.20M |
| Long-Term Investments | $16.88M | $23.90M | $6.95M | $0 | $0 | $20.06M | $28.95M | $13.01M |
| Other Non-Current Assets | $5.91M | $5.84M | $5.23M | $4.89M | $2.54M | $2.53M | $3.22M | $4.62M |
| Total Non-Current Assets | $87.64M | $97.61M | $83.32M | $79.11M | $79.76M | $103.2M | $120.6M | $111.3M |
| Total Assets | $273.9M | $311.2M | $350.6M | $340.1M | $408.0M | $385.5M | $429.8M | $490.9M |
| Accounts Payable | $4.04M | $3.88M | $5.47M | $2.89M | $2.57M | $3.38M | $3.73M | $5.37M |
| Total Current Liabilities | $46.27M | $39.87M | $36.95M | $49.41M | $31.88M | $36.90M | $41.28M | $53.79M |
| Other Non-Current Liabilities | $547K | $537K | $527K | $517K | $2.68M | $3.03M | $3.14M | $3.25M |
| Total Non-Current Liabilities | $34.86M | $37.47M | $40.01M | $42.44M | $46.97M | $49.63M | $51.99M | $54.25M |
| Total Liabilities | $81.13M | $77.34M | $76.96M | $91.85M | $78.84M | $86.53M | $93.28M | $108.0M |
| Total Debt (incl. Leases) | $44.28M | $46.60M | $48.85M | $50.99M | $53.07M | $55.11M | $57.09M | $58.97M |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $30K | $1.0K |
| Retained Earnings | -$1.73B | -$1.69B | -$1.64B | -$1.62B | -$1.48B | -$1.44B | -$1.40B | -$1.35B |
| Accumulated Other Comp. Income | -$278K | -$158K | -$9.0K | $242K | $201K | $57K | $158K | $291K |
| Total Stockholders' Equity | $192.7M | $233.8M | $273.7M | $248.2M | $329.1M | $298.9M | $336.5M | $382.8M |
| Total Equity | $192.7M | $233.8M | $273.7M | $248.2M | $329.1M | $298.9M | $336.5M | $382.8M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Net Income | -$274.4M | -$343.0M | -$234.6M | -$183.1M | -$250.2M | -$204.5M | -$129.4M |
| Depreciation & Amortization | $11.54M | $19.63M | $20.25M | $18.02M | $13.62M | $4.29M | $1.26M |
| Stock-Based Compensation | $41.83M | $33.14M | $47.08M | $81.92M | $62.20M | $33.26M | $15.73M |
| Change in Payables | -$2.34M | -$3.23M | $1.46M | $667K | $91K | -$278K | $1.71M |
| Operating Cash Flow | -$150.0M | -$162.4M | -$163.7M | -$169.6M | -$126.2M | -$160.9M | $39.47M |
| Capital Expenditure | -$780K | -$464K | -$2.69M | -$24.28M | -$65.50M | -$51.48M | -$16.05M |
| Free Cash Flow | -$150.8M | -$162.9M | -$166.4M | -$193.8M | -$191.8M | -$212.4M | $23.43M |
| Purchases of Investments | -$278.9M | -$394.7M | -$476.9M | -$406.3M | -$673.5M | -$864.9M | -$610.8M |
| Investing Cash Flow | $54.10M | $122.4M | $184.0M | -$11.54M | -$121.6M | -$273.5M | -$422.4M |
| Common Stock Issued | $50.00M | $0 | $0 | -- | -- | -- | -- |
| Share Repurchases | -- | -- | -- | $0 | $0 | -$11.81M | -$185K |
| Financing Cash Flow | $50.41M | $1.33M | $1.74M | $10.63M | $401.2M | $476.8M | $351.2M |
| Net Change in Cash | -$45.52M | -$38.64M | $22.10M | -$170.5M | $153.4M | $42.40M | -$31.80M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$45.53M | -$44.76M | -$24.15M | -$140.7M | -$38.85M | -$42.68M | -$52.20M | -$191.9M |
| Depreciation & Amortization | $2.05M | $2.22M | $2.33M | $2.40M | $2.57M | $3.13M | $3.44M | $5.03M |
| Stock-Based Compensation | $4.51M | $4.53M | $4.29M | $25.57M | $5.23M | $5.00M | $6.02M | $8.08M |
| Change in Payables | $144K | -$1.46M | $2.38M | $325K | -$779K | -$231K | -$1.65M | -$2.04M |
| Operating Cash Flow | -$34.57M | -$33.92M | -$38.51M | -$32.25M | -$28.58M | -$34.46M | -$54.74M | -$47.24M |
| Capital Expenditure | -$66K | -$256K | -$89K | -$304K | -$62K | -$168K | -$246K | -$44K |
| Free Cash Flow | -$34.63M | -$34.18M | -$38.60M | -$32.55M | -$28.64M | -$34.63M | -$54.98M | -$47.29M |
| Purchases of Investments | -$43.58M | -$53.52M | -$37.18M | -$42.80M | -$70.99M | -$80.70M | -$84.41M | -$38.80M |
| Investing Cash Flow | $53.59M | $15.62M | $17.38M | -$31.36M | $3.35M | $12.65M | $69.47M | $53.51M |
| Financing Cash Flow | $41K | $522K | $51.72M | $222K | $50.00M | $183K | $1.0K | $437K |
| Net Change in Cash | $19.07M | -$17.78M | $30.59M | -$63.39M | $24.77M | -$21.63M | $14.73M | $6.70M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -748344.4% | -588123.0% | -190006.2% | -220.9% | -2016.7% | -2732.6% | -15538.7% |
| Net Profit Margin | -762355.6% | -562285.2% | -180486.2% | -216.2% | -2349.5% | -2636.3% | -19692.1% |
| Return on Equity (ROE) | -110.6% | -89.6% | -35.8% | -22.0% | -26.9% | -- | -- |
| Return on Assets (ROA) | -80.7% | -69.9% | -31.3% | -19.5% | -22.2% | -22.5% | -- |
| Current Ratio | 5.28x | 7.06x | 16.07x | 17.59x | 13.40x | 12.53x | -- |
| Quick Ratio | 5.00x | 6.89x | 15.82x | 17.29x | 13.15x | 12.43x | -- |
| Debt to Equity | 0.21x | 0.15x | 0.10x | 0.08x | 0.07x | -- | -- |
| Revenue Growth (YoY) | -41.0% | -53.1% | -99.8% | +695.1% | +37.3% | +1080.5% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -507.5% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -1006.5% | -- |
| 5Y Revenue / Share Growth | -100.0% | -100.0% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1783580.0% | -949981.5% | -826767.7% | -748344.4% | -836358.5% | -593598.3% | -554687.7% | -588123.0% |
| Net Profit Margin | -1701066.7% | -920285.2% | -794858.1% | -762355.6% | -794292.7% | -552328.3% | -514649.2% | -562285.2% |
| Return on Equity (ROE) | -132.4% | -106.3% | -90.0% | -110.6% | -98.9% | -110.9% | -99.4% | -89.6% |
| Return on Assets (ROA) | -93.2% | -79.9% | -70.3% | -80.7% | -79.8% | -86.0% | -77.8% | -69.9% |
| Current Ratio | 4.02x | 5.36x | 7.23x | 5.28x | 10.30x | 7.65x | 7.49x | 7.06x |
| Quick Ratio | 3.83x | 5.12x | 6.88x | 5.00x | 10.03x | 7.50x | 7.30x | 6.89x |
| Debt to Equity | 0.23x | 0.20x | 0.18x | 0.21x | 0.16x | 0.18x | 0.17x | 0.15x |
| Revenue Growth (YoY) | -80.0% | -50.0% | -71.4% | -45.5% | -55.9% | -38.5% | +133.3% | -15.4% |